| very low density lipoprotein particle remodeling | GO:0034372 | 10 | 1.000 | |
| neutral lipid catabolic process | GO:0046461 | 12 | 1.000 | Human |
| high density lipoprotein particle remodeling | GO:0034375 | 8 | 1.000 | Human |
| macromolecular complex remodeling | GO:0034367 | 16 | 1.000 | |
| protein lipid complex remodeling | GO:0034368 | 16 | 1.000 | |
| regulation of lipid catabolic process | GO:0050994 | 23 | 1.000 | Human |
| plasma lipoprotein particle organization | GO:0071827 | 22 | 1.000 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 10 | 1.000 | |
| regulation of high density lipoprotein particle clearance | GO:0010982 | 2 | 1.000 | |
| cholesterol transport | GO:0030301 | 39 | 1.000 | |
| sterol transport | GO:0015918 | 39 | 1.000 | |
| protein lipid complex subunit organization | GO:0071825 | 24 | 1.000 | |
| organic hydroxy compound transport | GO:0015850 | 63 | 1.000 | |
| negative regulation of cholesterol transport | GO:0032375 | 8 | 1.000 | Human |
| sterol esterification | GO:0034434 | 10 | 1.000 | |
| phospholipid transport | GO:0015914 | 23 | 1.000 | |
| glycerolipid catabolic process | GO:0046503 | 18 | 1.000 | Human |
| negative regulation of sterol transport | GO:0032372 | 8 | 1.000 | Human |
| reverse cholesterol transport | GO:0043691 | 8 | 1.000 | |
| cholesterol import | GO:0070508 | 4 | 0.999 | |
| sterol homeostasis | GO:0055092 | 28 | 0.999 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 16 | 0.999 | |
| lipid transport | GO:0006869 | 90 | 0.999 | |
| ethanolamine containing compound metabolic process | GO:0042439 | 26 | 0.999 | |
| phosphatidylcholine biosynthetic process | GO:0006656 | 9 | 0.998 | |
| high density lipoprotein particle clearance | GO:0034384 | 6 | 0.998 | Human |
| glycerolipid metabolic process | GO:0046486 | 107 | 0.998 | |
| chylomicron remnant clearance | GO:0034382 | 4 | 0.998 | Human |
| regulation of triglyceride metabolic process | GO:0090207 | 11 | 0.998 | Human |
| acylglycerol metabolic process | GO:0006639 | 27 | 0.996 | Human |
| negative regulation of lipid catabolic process | GO:0050995 | 9 | 0.995 | |
| negative regulation of lipid metabolic process | GO:0045833 | 38 | 0.995 | Human |
| plasma lipoprotein particle clearance | GO:0034381 | 16 | 0.995 | Human |
| cholesterol esterification | GO:0034435 | 10 | 0.994 | |
| cellular biogenic amine metabolic process | GO:0006576 | 34 | 0.993 | |
| fatty acid metabolic process | GO:0006631 | 115 | 0.986 | Human |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.985 | |
| lipid metabolic process | GO:0006629 | 381 | 0.983 | |
| cellular lipid catabolic process | GO:0044242 | 65 | 0.983 | Human |
| organic anion transport | GO:0015711 | 103 | 0.981 | |
| high density lipoprotein particle assembly | GO:0034380 | 5 | 0.980 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.979 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.979 | |
| cholesterol homeostasis | GO:0042632 | 28 | 0.978 | |
| lipid localization | GO:0010876 | 106 | 0.976 | |
| triglyceride catabolic process | GO:0019433 | 10 | 0.971 | Human |
| very low density lipoprotein particle clearance | GO:0034447 | 6 | 0.971 | Human |
| neutral lipid metabolic process | GO:0006638 | 27 | 0.950 | Human |
| oxidation reduction process | GO:0055114 | 396 | 0.949 | |
| alcohol metabolic process | GO:0006066 | 114 | 0.945 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.933 | |
| negative regulation of very low density lipoprotein particle remodeling | GO:0010903 | 3 | 0.932 | |
| phospholipid catabolic process | GO:0009395 | 12 | 0.932 | |
| steroid metabolic process | GO:0008202 | 94 | 0.930 | |
| anion transport | GO:0006820 | 161 | 0.928 | |
| chemical homeostasis | GO:0048878 | 306 | 0.920 | |
| lipid homeostasis | GO:0055088 | 39 | 0.911 | |
| triglyceride rich lipoprotein particle clearance | GO:0071830 | 4 | 0.909 | Human |
| cdc42 protein signal transduction | GO:0032488 | 4 | 0.908 | |
| regulation of very low density lipoprotein particle remodeling | GO:0010901 | 4 | 0.900 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.896 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.882 | |
| positive regulation of cholesterol esterification | GO:0010873 | 6 | 0.847 | |
| regulation of lipase activity | GO:0060191 | 37 | 0.843 | Human |
| phospholipid metabolic process | GO:0006644 | 99 | 0.789 | |
| sterol transmembrane transport | GO:0035382 | 4 | 0.787 | |
| organophosphate ester transport | GO:0015748 | 32 | 0.783 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.760 | |
| regulation of lipid transport | GO:0032368 | 44 | 0.746 | Human Mouse |
| cholesterol efflux | GO:0033344 | 28 | 0.746 | |
| lipid modification | GO:0030258 | 84 | 0.737 | |
| regulation of fatty acid biosynthetic process | GO:0042304 | 9 | 0.735 | Human |
| phosphatidylcholine metabolic process | GO:0046470 | 19 | 0.734 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 12 | 0.730 | Human |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.718 | Human Mouse |
| regulation of receptor mediated endocytosis | GO:0048259 | 32 | 0.705 | |
| negative regulation of transport | GO:0051051 | 176 | 0.705 | |
| regulation of sterol transport | GO:0032371 | 21 | 0.697 | Human Mouse |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.686 | Mouse |
| rho protein signal transduction | GO:0007266 | 26 | 0.675 | |
| amine metabolic process | GO:0009308 | 44 | 0.665 | |
| glycerophospholipid metabolic process | GO:0006650 | 84 | 0.663 | |
| regulation of cdc42 protein signal transduction | GO:0032489 | 14 | 0.644 | |
| regulation of fatty acid metabolic process | GO:0019217 | 24 | 0.606 | Human |
| phospholipid efflux | GO:0033700 | 11 | 0.593 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.589 | Human |
| response to oxygen containing compound | GO:1901700 | 369 | 0.579 | Human |
| lipid catabolic process | GO:0016042 | 84 | 0.538 | Human |
| acylglycerol catabolic process | GO:0046464 | 12 | 0.523 | Human |
| fatty acid biosynthetic process | GO:0006633 | 46 | 0.507 | Human |
| negative regulation of catabolic process | GO:0009895 | 104 | 0.489 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 32 | 0.488 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.472 | Human |
| protein lipid complex assembly | GO:0065005 | 12 | 0.453 | |
| organophosphate biosynthetic process | GO:0090407 | 163 | 0.434 | |
| negative regulation of lipid transport | GO:0032369 | 18 | 0.411 | Human |
| mapk cascade | GO:0000165 | 288 | 0.405 | Human |
| organophosphate catabolic process | GO:0046434 | 430 | 0.403 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.401 | |
| sterol metabolic process | GO:0016125 | 28 | 0.396 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 71 | 0.396 | |
| negative regulation of cellular catabolic process | GO:0031330 | 83 | 0.374 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.364 | Human |
| transmembrane transport | GO:0055085 | 399 | 0.348 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 67 | 0.336 | Human |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.333 | Human |
| glycerolipid biosynthetic process | GO:0045017 | 51 | 0.326 | |
| negative regulation of cytokine production | GO:0001818 | 82 | 0.325 | |
| postsynaptic membrane organization | GO:0001941 | 2 | 0.323 | Human |
| negative regulation of lipoprotein particle clearance | GO:0010985 | 5 | 0.322 | |
| positive regulation of lipid metabolic process | GO:0045834 | 50 | 0.321 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.317 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.293 | |
| negative regulation of lipid biosynthetic process | GO:0051055 | 22 | 0.279 | Human |
| lipoprotein metabolic process | GO:0042157 | 42 | 0.260 | Human Mouse |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.258 | Human |
| regulation of cytokine production | GO:0001817 | 232 | 0.247 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.244 | Human |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.238 | |
| coagulation | GO:0050817 | 78 | 0.237 | Human |
| regulation of secretion by cell | GO:1903530 | 177 | 0.233 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.229 | Human |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.226 | |
| regulation of immune response | GO:0050776 | 201 | 0.224 | |
| negative regulation of endocytosis | GO:0045806 | 19 | 0.223 | |
| negative regulation of cell migration | GO:0030336 | 102 | 0.220 | Human |
| regulation of cell adhesion | GO:0030155 | 166 | 0.220 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.217 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.210 | Human |
| negative regulation of hydrogen peroxide metabolic process | GO:0010727 | 3 | 0.205 | |
| negative regulation of receptor mediated endocytosis | GO:0048261 | 6 | 0.202 | |
| plasma lipoprotein particle assembly | GO:0034377 | 9 | 0.201 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.200 | |
| regeneration | GO:0031099 | 4 | 0.200 | Human |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.198 | Human |
| cell substrate adhesion | GO:0031589 | 132 | 0.198 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.185 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 40 | 0.184 | |
| negative regulation of secretion by cell | GO:1903531 | 52 | 0.183 | |
| regulation of triglyceride catabolic process | GO:0010896 | 6 | 0.181 | Human |
| carboxylic acid biosynthetic process | GO:0046394 | 97 | 0.180 | Human |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.178 | |
| response to inorganic substance | GO:0010035 | 127 | 0.173 | Human |
| regulation of phospholipase c activating g protein coupled receptor signaling pathway | GO:1900736 | 1 | 0.172 | |
| tissue regeneration | GO:0042246 | 3 | 0.167 | Human |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.165 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.161 | |
| cell adhesion molecule production | GO:0060352 | 3 | 0.156 | |
| protein maturation | GO:0051604 | 233 | 0.155 | |
| sterol import | GO:0035376 | 4 | 0.153 | |
| response to transition metal nanoparticle | GO:1990267 | 29 | 0.152 | |
| negative regulation of transmembrane transport | GO:0034763 | 29 | 0.145 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.141 | Human |
| epithelium migration | GO:0090132 | 119 | 0.140 | Human Mouse |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.138 | |
| positive regulation of vasoconstriction | GO:0045907 | 3 | 0.135 | |
| phospholipid biosynthetic process | GO:0008654 | 44 | 0.134 | |
| regulation of vesicle mediated transport | GO:0060627 | 130 | 0.133 | |
| regulation of coagulation | GO:0050818 | 44 | 0.133 | Human |
| response to metal ion | GO:0010038 | 84 | 0.130 | |
| negative regulation of lipase activity | GO:0060192 | 8 | 0.128 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.127 | |
| regulation of locomotion | GO:0040012 | 329 | 0.125 | Human |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.123 | |
| response to reactive oxygen species | GO:0000302 | 61 | 0.122 | Human |
| negative regulation of cytokine production involved in immune response | GO:0002719 | 13 | 0.120 | |
| regulation of oxidoreductase activity | GO:0051341 | 43 | 0.113 | Human |
| regulation of protein localization | GO:0032880 | 296 | 0.112 | |
| response to wounding | GO:0009611 | 168 | 0.111 | |
| regulation of heterotypic cell cell adhesion | GO:0034114 | 14 | 0.111 | |
| regulation of cholesterol metabolic process | GO:0090181 | 4 | 0.111 | Human |
| lipopolysaccharide transport | GO:0015920 | 2 | 0.108 | |
| response to oxidative stress | GO:0006979 | 121 | 0.106 | Human |
| regulation of cholesterol esterification | GO:0010872 | 7 | 0.106 | |
| regulation of secretion | GO:0051046 | 194 | 0.106 | |
| immune response | GO:0006955 | 307 | 0.106 | |
| retina homeostasis | GO:0001895 | 42 | 0.102 | |
| regulation of lipid biosynthetic process | GO:0046890 | 47 | 0.101 | Human |
| regulation of proteolysis | GO:0030162 | 293 | 0.100 | Human |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 156 | 0.099 | |
| multicellular organismal metabolic process | GO:0044236 | 34 | 0.099 | Human |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.096 | Human |
| negative regulation of lipoprotein lipase activity | GO:0051005 | 5 | 0.094 | |
| alcohol biosynthetic process | GO:0046165 | 52 | 0.093 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.093 | Mouse |
| ameboidal type cell migration | GO:0001667 | 135 | 0.093 | Human Mouse |
| negative regulation of immune response | GO:0050777 | 40 | 0.091 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.090 | |
| regulation of cholesterol transport | GO:0032374 | 21 | 0.089 | Human Mouse |
| regulation of protein stability | GO:0031647 | 87 | 0.089 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.087 | |
| protein secretion | GO:0009306 | 98 | 0.081 | |
| tissue migration | GO:0090130 | 119 | 0.080 | Human Mouse |
| positive regulation of rho protein signal transduction | GO:0035025 | 4 | 0.080 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.079 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.078 | Human |
| small molecule catabolic process | GO:0044282 | 92 | 0.078 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.078 | Human |
| cytokine biosynthetic process | GO:0042089 | 37 | 0.077 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.077 | |
| regulation of chemotaxis | GO:0050920 | 74 | 0.077 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.075 | Human |
| positive regulation of locomotion | GO:0040017 | 186 | 0.074 | |
| response to steroid hormone | GO:0048545 | 80 | 0.072 | |
| negative regulation of interleukin 1 secretion | GO:0050711 | 4 | 0.072 | |
| triglyceride metabolic process | GO:0006641 | 23 | 0.072 | Human |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.071 | |
| low density lipoprotein particle remodeling | GO:0034374 | 6 | 0.071 | |
| response to hormone | GO:0009725 | 175 | 0.071 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.069 | |
| neurotransmitter gated ion channel clustering | GO:0072578 | 1 | 0.068 | Human |
| regulation of protein transport | GO:0051223 | 213 | 0.068 | |
| blood vessel endothelial cell migration | GO:0043534 | 42 | 0.068 | Human Mouse |
| wound healing | GO:0042060 | 115 | 0.067 | Human |
| cholesterol metabolic process | GO:0008203 | 28 | 0.066 | |
| hydrogen peroxide catabolic process | GO:0042744 | 13 | 0.065 | Human |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.065 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.065 | Human |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.065 | |
| circulatory system process | GO:0003013 | 113 | 0.064 | |
| organic hydroxy compound catabolic process | GO:1901616 | 22 | 0.063 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.063 | |
| cellular response to hydrogen peroxide | GO:0070301 | 37 | 0.063 | Human |
| response to nitrogen compound | GO:1901698 | 184 | 0.063 | |
| regulation of cell development | GO:0060284 | 161 | 0.060 | |
| anatomical structure homeostasis | GO:0060249 | 100 | 0.060 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.059 | |
| receptor mediated endocytosis | GO:0006898 | 84 | 0.059 | Human |
| regulation of response to wounding | GO:1903034 | 101 | 0.059 | |
| positive regulation of monooxygenase activity | GO:0032770 | 14 | 0.058 | Human |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.058 | Human |
| regulation of erk1 and erk2 cascade | GO:0070372 | 99 | 0.058 | |
| post embryonic development | GO:0009791 | 2 | 0.058 | |
| regulation of protein processing | GO:0070613 | 150 | 0.058 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.057 | Human |
| tissue homeostasis | GO:0001894 | 63 | 0.057 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.055 | |
| regulation of hormone secretion | GO:0046883 | 57 | 0.055 | |
| regulation of cell cell adhesion | GO:0022407 | 57 | 0.055 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.055 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.054 | |
| cellular amide metabolic process | GO:0043603 | 69 | 0.054 | Human |
| cyclic nucleotide metabolic process | GO:0009187 | 82 | 0.053 | Human |
| positive regulation of lipid biosynthetic process | GO:0046889 | 22 | 0.052 | Human |
| negative regulation of epithelial cell migration | GO:0010633 | 38 | 0.052 | Human |
| intracellular protein transport | GO:0006886 | 270 | 0.051 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.050 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.049 | Human |
| biological adhesion | GO:0022610 | 331 | 0.048 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.048 | |
| endocytosis | GO:0006897 | 159 | 0.048 | Human |
| response to other organism | GO:0051707 | 261 | 0.048 | |
| positive regulation of lipoprotein lipase activity | GO:0051006 | 7 | 0.048 | Human |
| nucleotide biosynthetic process | GO:0009165 | 109 | 0.047 | Human |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.047 | Mouse |
| regulation of response to oxidative stress | GO:1902882 | 26 | 0.047 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.046 | Human |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.046 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.046 | Human |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.046 | |
| blood coagulation | GO:0007596 | 76 | 0.045 | Human |
| positive regulation of oxidoreductase activity | GO:0051353 | 26 | 0.045 | Human |
| secretion by cell | GO:0032940 | 226 | 0.045 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 82 | 0.045 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.045 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.044 | Human |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.044 | |
| negative regulation of fatty acid metabolic process | GO:0045922 | 8 | 0.044 | |
| membrane organization | GO:0061024 | 292 | 0.043 | Human |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.043 | Human |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.043 | |
| response to copper ion | GO:0046688 | 8 | 0.042 | |
| regulation of cell motility | GO:2000145 | 299 | 0.042 | Human |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.042 | |
| regulation of protein maturation | GO:1903317 | 150 | 0.042 | |
| maintenance of organelle location | GO:0051657 | 4 | 0.042 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.041 | Human |
| response to lipid | GO:0033993 | 206 | 0.041 | |
| protein localization to membrane | GO:0072657 | 160 | 0.040 | Human |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.040 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.040 | |
| cell activation | GO:0001775 | 213 | 0.040 | Human |
| regulation of cellular response to oxidative stress | GO:1900407 | 26 | 0.040 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.039 | Human |
| positive regulation of gliogenesis | GO:0014015 | 4 | 0.039 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.039 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 42 | 0.039 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.039 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.039 | |
| cellular homeostasis | GO:0019725 | 196 | 0.039 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.038 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.037 | |
| response to hydrogen peroxide | GO:0042542 | 40 | 0.037 | Human |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.037 | |
| response to corticosteroid | GO:0031960 | 15 | 0.037 | |
| regulation of cell substrate adhesion | GO:0010810 | 68 | 0.037 | |
| protein activation cascade | GO:0072376 | 22 | 0.037 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 37 | 0.036 | |
| amide transport | GO:0042886 | 76 | 0.036 | |
| tube development | GO:0035295 | 125 | 0.035 | |
| interleukin 1 production | GO:0032612 | 26 | 0.035 | |
| alcohol catabolic process | GO:0046164 | 20 | 0.035 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.035 | Human |
| steroid biosynthetic process | GO:0006694 | 46 | 0.035 | Human Mouse |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.034 | |
| segmentation | GO:0035282 | 4 | 0.034 | |
| regulation of endocytosis | GO:0030100 | 72 | 0.034 | |
| positive regulation of interleukin 8 biosynthetic process | GO:0045416 | 8 | 0.034 | |
| transmission of nerve impulse | GO:0019226 | 11 | 0.034 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.034 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.034 | |
| protein processing | GO:0016485 | 226 | 0.034 | |
| sprouting angiogenesis | GO:0002040 | 29 | 0.034 | |
| regulation of response to reactive oxygen species | GO:1901031 | 12 | 0.034 | |
| chemotaxis | GO:0006935 | 157 | 0.033 | |
| cytokine secretion | GO:0050663 | 64 | 0.033 | |
| regulation of transporter activity | GO:0032409 | 82 | 0.033 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.033 | Human |
| protein folding | GO:0006457 | 38 | 0.033 | |
| regulation of interleukin 8 production | GO:0032677 | 49 | 0.033 | |
| platelet activation | GO:0030168 | 44 | 0.033 | Human |
| positive regulation of hormone secretion | GO:0046887 | 25 | 0.033 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.032 | |
| plasma membrane organization | GO:0007009 | 115 | 0.032 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.032 | |
| protein localization to plasma membrane | GO:0072659 | 93 | 0.032 | |
| response to cytokine | GO:0034097 | 232 | 0.032 | |
| positive regulation of lipid catabolic process | GO:0050996 | 13 | 0.032 | Human |
| cellular response to reactive oxygen species | GO:0034614 | 50 | 0.031 | Human |
| regulation of mapk cascade | GO:0043408 | 262 | 0.031 | Human |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.031 | |
| cell adhesion | GO:0007155 | 325 | 0.031 | |
| metal ion transport | GO:0030001 | 272 | 0.031 | |
| negative regulation of production of molecular mediator of immune response | GO:0002701 | 13 | 0.030 | |
| single organism membrane organization | GO:0044802 | 268 | 0.030 | Human |
| regulation of system process | GO:0044057 | 101 | 0.030 | Mouse |
| locomotory behavior | GO:0007626 | 1 | 0.030 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 207 | 0.030 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.030 | Human Mouse |
| regulation of carbohydrate metabolic process | GO:0006109 | 54 | 0.030 | |
| heterotypic cell cell adhesion | GO:0034113 | 28 | 0.029 | |
| hydrogen peroxide metabolic process | GO:0042743 | 20 | 0.029 | Human |
| protein dephosphorylation | GO:0006470 | 81 | 0.029 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.029 | |
| skeletal muscle satellite cell proliferation | GO:0014841 | 1 | 0.029 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.029 | |
| endomembrane system organization | GO:0010256 | 196 | 0.029 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.028 | Human |
| negative regulation of synaptic transmission | GO:0050805 | 2 | 0.028 | |
| system process | GO:0003008 | 349 | 0.028 | Mouse |
| cellular component morphogenesis | GO:0032989 | 314 | 0.028 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 38 | 0.028 | Human |
| regulation of cell differentiation | GO:0045595 | 393 | 0.028 | |
| regulation of cell projection organization | GO:0031344 | 107 | 0.028 | Human |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.028 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.028 | |
| organic acid catabolic process | GO:0016054 | 71 | 0.028 | |
| ribose phosphate biosynthetic process | GO:0046390 | 82 | 0.028 | Human |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.028 | |
| positive regulation of endothelial cell migration | GO:0010595 | 39 | 0.028 | |
| cellular carbohydrate metabolic process | GO:0044262 | 84 | 0.028 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.027 | Human Mouse |
| phosphatidylcholine catabolic process | GO:0034638 | 3 | 0.027 | |
| peptide secretion | GO:0002790 | 51 | 0.027 | |
| negative regulation of protein processing | GO:0010955 | 142 | 0.027 | |
| hormone secretion | GO:0046879 | 65 | 0.027 | |
| modification of morphology or physiology of other organism | GO:0035821 | 43 | 0.027 | |
| regulation of cell migration | GO:0030334 | 289 | 0.027 | Human |
| negative regulation of interleukin 1 beta secretion | GO:0050713 | 2 | 0.027 | |
| response to nutrient levels | GO:0031667 | 81 | 0.027 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.026 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 24 | 0.026 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.026 | |
| negative regulation of blood coagulation | GO:0030195 | 22 | 0.026 | Human |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.026 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.026 | |
| lymphocyte homeostasis | GO:0002260 | 4 | 0.026 | |
| negative regulation of cytokine mediated signaling pathway | GO:0001960 | 22 | 0.026 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.026 | |
| response to glucocorticoid | GO:0051384 | 13 | 0.026 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.026 | Human |
| regulation of blood vessel endothelial cell migration | GO:0043535 | 30 | 0.026 | Human |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.025 | |
| long term memory | GO:0007616 | 2 | 0.025 | |
| positive regulation of protein catabolic process | GO:0045732 | 75 | 0.025 | Human |
| positive regulation of response to wounding | GO:1903036 | 28 | 0.025 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 75 | 0.025 | |
| negative regulation of cell motility | GO:2000146 | 104 | 0.025 | Human |
| negative regulation of reactive oxygen species metabolic process | GO:2000378 | 11 | 0.025 | |
| negative regulation of gliogenesis | GO:0014014 | 3 | 0.025 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.025 | Human |
| positive regulation of secretion | GO:0051047 | 116 | 0.025 | |
| regulation of immune effector process | GO:0002697 | 91 | 0.025 | |
| hexose metabolic process | GO:0019318 | 55 | 0.024 | |
| regulation of defense response | GO:0031347 | 154 | 0.024 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.024 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.024 | |
| regulation of protein ubiquitination | GO:0031396 | 95 | 0.024 | |
| response to carbohydrate | GO:0009743 | 21 | 0.023 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.023 | Human |
| dephosphorylation | GO:0016311 | 209 | 0.023 | |
| regulation of anatomical structure size | GO:0090066 | 101 | 0.023 | |
| activation of transmembrane receptor protein tyrosine kinase activity | GO:0007171 | 4 | 0.023 | |
| receptor metabolic process | GO:0043112 | 81 | 0.023 | Human |
| protein catabolic process | GO:0030163 | 325 | 0.023 | Human |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 107 | 0.023 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.022 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.022 | |
| maintenance of location | GO:0051235 | 112 | 0.022 | Mouse |
| regulation of growth | GO:0040008 | 165 | 0.022 | |
| astrocyte differentiation | GO:0048708 | 4 | 0.022 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.022 | Human |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.022 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.022 | |
| female gamete generation | GO:0007292 | 2 | 0.022 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 7 | 0.022 | Human |
| glycoprotein metabolic process | GO:0009100 | 110 | 0.022 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.022 | |
| blood vessel development | GO:0001568 | 172 | 0.022 | |
| interleukin 8 production | GO:0032637 | 51 | 0.022 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 89 | 0.022 | |
| oogenesis | GO:0048477 | 2 | 0.022 | |
| elastic fiber assembly | GO:0048251 | 3 | 0.022 | |
| developmental growth | GO:0048589 | 48 | 0.022 | Human |
| positive regulation of triglyceride lipase activity | GO:0061365 | 7 | 0.022 | Human |
| positive regulation of phospholipid transport | GO:2001140 | 4 | 0.022 | Human |
| protein ubiquitination | GO:0016567 | 314 | 0.021 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.021 | |
| membrane protein ectodomain proteolysis | GO:0006509 | 33 | 0.021 | Human |
| activation of protein kinase activity | GO:0032147 | 90 | 0.021 | |
| secretion | GO:0046903 | 254 | 0.021 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.021 | |
| cytokine mediated signaling pathway | GO:0019221 | 109 | 0.021 | |
| presynaptic membrane organization | GO:0097090 | 3 | 0.020 | Human |
| regulation of behavior | GO:0050795 | 82 | 0.020 | |
| blood circulation | GO:0008015 | 113 | 0.020 | |
| glucose metabolic process | GO:0006006 | 45 | 0.020 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.020 | Human |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 18 | 0.020 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.020 | Human |
| response to calcium ion | GO:0051592 | 46 | 0.020 | |
| sequestering of metal ion | GO:0051238 | 24 | 0.020 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 11 | 0.020 | Human |
| intermediate filament cytoskeleton organization | GO:0045104 | 17 | 0.020 | |
| negative regulation of mapk cascade | GO:0043409 | 56 | 0.020 | Human |
| mrna metabolic process | GO:0016071 | 175 | 0.020 | |
| regulation of nervous system development | GO:0051960 | 88 | 0.019 | Human |
| regulation of inflammatory response | GO:0050727 | 46 | 0.019 | |
| defense response to other organism | GO:0098542 | 129 | 0.019 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 83 | 0.019 | |
| negative regulation of cell adhesion molecule production | GO:0060354 | 1 | 0.019 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.019 | |
| regulation of glial cell differentiation | GO:0045685 | 3 | 0.019 | |
| negative regulation of response to oxidative stress | GO:1902883 | 18 | 0.019 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.019 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.019 | |
| vascular process in circulatory system | GO:0003018 | 29 | 0.019 | |
| positive regulation of transport | GO:0051050 | 336 | 0.019 | Human |
| cell morphogenesis | GO:0000902 | 296 | 0.019 | |
| cell migration involved in gastrulation | GO:0042074 | 1 | 0.019 | |
| negative regulation of tumor necrosis factor production | GO:0032720 | 20 | 0.019 | |
| dendritic spine maintenance | GO:0097062 | 1 | 0.019 | Human |
| cytoplasmic transport | GO:0016482 | 379 | 0.019 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.019 | Human |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.018 | |
| negative regulation of endothelial cell apoptotic process | GO:2000352 | 16 | 0.018 | |
| negative regulation of vasculature development | GO:1901343 | 43 | 0.018 | |
| response to peptide | GO:1901652 | 65 | 0.018 | |
| regulation of interleukin 1 production | GO:0032652 | 21 | 0.018 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.018 | |
| epithelium development | GO:0060429 | 227 | 0.018 | |
| positive regulation of cgmp biosynthetic process | GO:0030828 | 3 | 0.018 | Human |
| single organism cellular localization | GO:1902580 | 332 | 0.018 | Human |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.018 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.018 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 60 | 0.018 | Human |
| regulation of receptor catabolic process | GO:2000644 | 2 | 0.018 | Human |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.018 | |
| growth | GO:0040007 | 202 | 0.018 | Human |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.018 | |
| positive regulation of exocytosis | GO:0045921 | 35 | 0.018 | |
| regulation of endothelial cell apoptotic process | GO:2000351 | 24 | 0.018 | |
